Addex Therapeutics (XSWX:ADXN) 3-Year Book Growth Rate : -74.40% (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Addex Therapeutics 3-Year Book Growth Rate?

Addex Therapeutics's Book Value per Share for the quarter that ended in Dec. 2023 was CHF0.01.

During the past 12 months, Addex Therapeutics's average Book Value per Share Growth Rate was -85.90% per year. During the past 3 years, the average Book Value per Share Growth Rate was -74.40% per year. During the past 5 years, the average Book Value per Share Growth Rate was -62.00% per year. During the past 10 years, the average Book Value per Share Growth Rate was -9.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Addex Therapeutics was 269.60% per year. The lowest was -74.40% per year. And the median was -41.10% per year.

Competitive Comparison of Addex Therapeutics's 3-Year Book Growth Rate

For the Biotechnology subindustry, Addex Therapeutics's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Addex Therapeutics's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Addex Therapeutics's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Addex Therapeutics's 3-Year Book Growth Rate falls into.

Addex Therapeutics 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Addex Therapeutics (XSWX:ADXN) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Addex Therapeutics 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Addex Therapeutics's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Addex Therapeutics (XSWX:ADXN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Addex Therapeutics Ltd (XSWX:ADXN) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

ADXN:USA ADXNz:UK APE1:Germany

Address

Chemin des Aulx 12, Plan-les-Ouates, P.O. Box 68, Geneva, CHE, 1202

Website

https://www.addextherapeutics.com

Addex Therapeutics Ltd is a biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe.

Addex Therapeutics (XSWX:ADXN) Headlines

From GuruFocus

Enamine Extend Collaboration With Prominent Swiss Biotech

By Business Wire Business Wire • 02-24-2021

Thinking about buying stock in Applovin, Sonos, WiMi Hologram Cloud, Addex Therapeutics, or Snap?

By PRNewswire PRNewswire • 02-09-2023